Meet us | IDL Biotech
IDL Biotech


September 2018

Meet us

IDL will attend the following meetings during autumn 2018

* The Swedish Urology meeting in Umeå,                           October 3-5 2018

* Bioteknikdagarna at KTH in Stockholm,                          November 16 2018

* Medica in Düsseldorf, November 12-15 2018, 3AD28


* ISOBM in Hamburg, November 24-27 2018                                  .

* Region days in urology in Karlstad,                         January 24-25 2019

To get in contact, please use our contact form that you will find here

IDL Biotech signs distributor agreement in Ghana

IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF.

IDL Biotech includes additional clinics in its ongoing multicenter study for UBC® Rapid in Sweden.

IDL Biotech currently has a number of ongoing clinical studies both internationally and in Sweden, with the aim of demonstrating the clinical benefit of UBC® Rapid in bladder cancer and having the test included as a complement in the follow-up of patients with bladder cancer who are classified as high risk.

IDL Biotech

Skip this intro